News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Melissa Mavers: Saddened to hear of the passing of Albert Bendelac, a true pioneer in the field of NKT cell biology!
Photo of Albert Bendelac from Melissa Mavers/Twitter
Sep 9, 2023, 20:22

Melissa Mavers: Saddened to hear of the passing of Albert Bendelac, a true pioneer in the field of NKT cell biology!

Quoting Melissa Mavers, Assistant Professor of Pediatrics in the Division of Hematology and Oncology at Washington University School of Medicine in St. Louis, on X/Twitter:

”Saddened to hear of the passing of Albert Bendelac, a true pioneer in the field of NKT cell biology!”

For the article click here.
Source: Melissa Mavers/Twitter

 

Albert Bendelac cancer Melissa Mavers NKT cell biology OncoDaily Oncology
Special Coverage
Career
Dec 31, 2024, 04:43
OncoInfluencers to Follow on Social Media: Jasmina Koeva
Positive
Dec 31, 2024, 03:42
Improving the lives of children with cancer everywhere - St. Jude Children's Research Hospital
Blog
Dec 31, 2024, 03:37
Matthew Pech: The failure of ex vivo gene therapy for sickle cell and the role of the TPP in the drug development process
Science
Dec 31, 2024, 03:34
Cristian Ochoa Arnedo: Empowerment among breast cancer survivors using an online peer support community
Blog
Dec 30, 2024, 19:52
CelloType: A New Machine Learning Tool for Analyzing Cancer Cells and Tissues
Blog
Dec 30, 2024, 19:26
“QI Scholar Nursing Presentations Part 2” from the SIOP Nursing Network
Science
Dec 30, 2024, 13:52
Nico Gagelmann: Selected clinical studies 2024 in hematology
Insight
Dec 30, 2024, 13:43
Roupen Odabashian: When it comes to real-life cases, physicians still outperform AI
Blog
Dec 30, 2024, 13:42
Shaban Juma: The key to being one step ahead in the fight against cancer
Insight
Dec 30, 2024, 13:35
James Crowley: Elevated expression of CCR7 is generally indicative of poor prognosis in cancers
Insight
Dec 30, 2024, 13:30
Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer
Blog
Dec 30, 2024, 13:25
Sanjay Popat: Wouldn’t it be great if FDA Oncology approvals were mutually approvable by MHRA?